Back to GILD

GILEAD SCIENCES, INC. Share-Based Compensation 2007-2026 | GILD

Beta

What is share-based compensation?

Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.

What is GILEAD SCIENCES, INC.'s current share-based compensation?

GILEAD SCIENCES, INC. (GILD) annual share-based compensation for 2025 was $894.0M, a 7.07% increase from 2024. GILEAD SCIENCES, INC. share-based compensation for the quarter ending March 31, 2026 was $218.0M.

What was GILEAD SCIENCES, INC.'s share-based compensation in 2024?

GILEAD SCIENCES, INC. annual share-based compensation for 2024 was $835.0M, a 9.01% increase from 2023.

What was GILEAD SCIENCES, INC.'s share-based compensation in 2023?

GILEAD SCIENCES, INC. annual share-based compensation for 2023 was $766.0M, a 20.25% increase from 2022.

What is GILEAD SCIENCES, INC.'s 5-year share-based compensation CAGR?

GILEAD SCIENCES, INC. share-based compensation grew at a compound annual growth rate (CAGR) of 6.81% from FY2020 to FY2025, going from $643.0M to $894.0M over 5 years.

Share-Based Compensation History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGR+6.8%
FY2020
$643.0M
FY2025
$894.0M
07080910111213141516171819202122232425
5 years selected
Share-Based Compensation History
PeriodValueChangeSource
FY2025$894.0M+7.1%10-K
FY2024$835.0M+9.0%10-K
FY2023$766.0M+20.3%10-K
FY2022$637.0M+0.3%10-K
FY2021$635.0M-1.2%10-K
FY2020$643.0M+1.1%10-K
FY2019$636.0M-24.7%10-K
FY2018$845.0M+32.4%10-K
FY2017$638.0M+67.9%10-K
FY2016$380.0M-0.5%10-K
FY2015$382.0M+6.1%10-K
FY2014$360.0M+42.9%10-K
FY2013$252.0M+20.6%10-K
FY2012$209.0M+8.6%10-K
FY2011$192.4M-3.8%10-K
FY2010$200.0M+10.7%10-K
FY2009$180.7M+17.8%10-K
FY2008$153.4M-16.9%10-K
FY2007$184.6M-10-K
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →